238 related articles for article (PubMed ID: 1914200)
1. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Biglieri EG; Kater CE
Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
[TBL] [Abstract][Full Text] [Related]
2. Steroids and hypertension.
Mantero F; Armanini D; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
J Steroid Biochem Mol Biol; 1991; 40(1-3):35-44. PubMed ID: 1958539
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoids in congenital adrenal hyperplasia.
Biglieri EG; Kater CE
J Steroid Biochem Mol Biol; 1991; 40(4-6):493-9. PubMed ID: 1958551
[TBL] [Abstract][Full Text] [Related]
4. New aspects of mineralocorticoid hypertension.
Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
[TBL] [Abstract][Full Text] [Related]
5. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
[TBL] [Abstract][Full Text] [Related]
6. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
[TBL] [Abstract][Full Text] [Related]
8. Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
Marques P; Tufton N; Bhattacharya S; Caulfield M; Akker SA
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051469
[TBL] [Abstract][Full Text] [Related]
9. Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.
Cerame BI; New MI
J Pediatr Endocrinol Metab; 2000; 13(9):1537-47. PubMed ID: 11154148
[TBL] [Abstract][Full Text] [Related]
10. Concurrent hypercortisolism and hypermineralocorticoidism.
Hogan MJ; Schambelan M; Biglieri EG
Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
[TBL] [Abstract][Full Text] [Related]
11. Investigating mineralocorticoid hypertension.
Nussberger J
J Hypertens Suppl; 2003 May; 21(2):S25-30. PubMed ID: 12929904
[TBL] [Abstract][Full Text] [Related]
12. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
[TBL] [Abstract][Full Text] [Related]
13. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI
J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
15. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
Roger M; Nahoul K; Laloy E; Scholler R
Ann Med Interne (Paris); 1983; 134(3):238-41. PubMed ID: 6625419
[TBL] [Abstract][Full Text] [Related]
16. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
[TBL] [Abstract][Full Text] [Related]
17. Classic and current concepts in adrenal steroidogenesis: a reappraisal.
Kater CE; Giorgi RB; Costa-Barbosa FA
Arch Endocrinol Metab; 2022 Mar; 66(1):77-87. PubMed ID: 35263051
[TBL] [Abstract][Full Text] [Related]
18. [Mineralocorticoid-induced hypertension].
Hensen J; Oelkers W
Med Klin (Munich); 1997 May; 92(5):273-8. PubMed ID: 9244833
[TBL] [Abstract][Full Text] [Related]
19. A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings.
Abdelhamid S; Lewicka S; Vecsei P; Haack D; Pahl S; Remberger K; Müller-Lobeck H; Bönhof JA; Nensel U; Röckel A
J Clin Endocrinol Metab; 1995 Mar; 80(3):737-44. PubMed ID: 7883826
[TBL] [Abstract][Full Text] [Related]
20. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
